Breast cancer Clinical Trials in Denver, CO
As of September 2026, 20 paid clinical trials are recruiting for Breast cancer in Denver, Colorado. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Denver
Filter results
20 clinical trials for Breast cancer
·Clear filters·A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
The Vanguard Study: Testing a New Way to Screen for Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
The Immune System's Response to Young Women's Breast Cancer
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Top Research Study Locations in Denver
Researchers run research studies in Denver, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Colorado Blood Cancer Institute | Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Myeloid Leukemia | 43 |
| National Jewish Health | Cystic Fibrosis, Pulmonary Hypertension, Asthma | 41 |
| Sarah Cannon Research Institute at HealthONE | Advanced Solid Tumor, Solid Tumor, Metastatic Solid Tumor | 26 |
| Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Mixed Phenotype Acute Leukemia | 17 |
| Rocky Mountain Cancer Centers | Breast Cancer, Colorectal Neoplasms, Prostate Cancer | 15 |
| Kaiser Permanente-Franklin | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 14 |
| UCHealth - Cherry Creek | Anatomic Stage II Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | 14 |
| University of Colorado | B Cell Lymphoma, B-Cell Non-Hodgkin's Lymphoma, CADASIL | 13 |
| Children's Hospital Colorado | ALL, AML, Acute Respiratory Distress Syndrome | 12 |
| Denver Health Medical Center | Acute Respiratory Failure, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 11 |
| University of Colorado Denver | Amyotrophic Lateral Sclerosis, Attention, Behavioral Variant Frontotemporal Dementia (bvFTD) | 10 |
| Denver Health and Hospital Authority | Sepsis, ARDS, Acute Otitis Media | 9 |
| Saint Joseph Hospital - Cancer Centers of Colorado | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 8 |
| AdventHealth Porter | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 7 |
| Sarah Cannon Research Institute | Gastric Cancer, Locally Advanced or Metastatic Solid Tumors, Pancreatic Cancer | 7 |
| Mountain View Clinical Research | Major Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant | 6 |
| National Jewish Health-Main Campus | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 6 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Urothelial Cancer, Advanced/Metastatic Urothelial Cancer | 5 |
| Cancer Center of Colorado at Sloan's Lake | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 5 |
| Children's Hospital of Colorado | Adolescent, Bowel Incontinence, CBL Syndrome | 5 |
| Denver Arthritis Clinic - Lowry | Gout, Psoriatic Arthritis, Systemic Lupus Erythematosus | 5 |
| Presbyterian - Saint Lukes Medical Center - Health One | Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| Rocky Mountain Cancer Centers-Midtown | Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| Rocky Mountain Cancer Centers-Rose | Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| University of Colorado, Denver | ACUTE SINUSITIS, ARDS, Acute Otitis Media (AOM) | 5 |
Active & Upcoming Studies in Denver (2026)
Recruiting trials in Denver grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (217 active studies)
- Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment · University of Colorado, Denver
- A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma · Phase 2 · SCRI Development Innovations, LLC
Cardiovascular (17 active studies)
- Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure · Phase 2 · Johns Hopkins University
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Mental health & behavior (10 active studies)
- Feasibility of a Modified Dental Comfort Position for Pediatric Patients Receiving Dental Exams · Children's Hospital Colorado
- Device for Treating Generalized Anxiety · BTL Industries Ltd.
Diabetes & metabolic (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes · Insulet Corporation
Pediatric (9 active studies)
- Feasibility of a Modified Dental Comfort Position for Pediatric Patients Receiving Dental Exams · Children's Hospital Colorado
- Meet Me on the Pitch: Developing and Testing a Community-Based Sports and Behavioral Health Intervention for Youth · University of California, San Francisco
Neurology & pain (7 active studies)
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- CF Wellness Program · Johns Hopkins University
Eye & vision (7 active studies)
- A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) · Phase 3 · Merck Sharp & Dohme LLC
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
HIV / STI (4 active studies)
Vaccines (2 active studies)
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia. · Phase 2 · Vasomune Therapeutics, Inc.
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry · Massive Bio, Inc.
Common conditions studied in Denver
- Multiple Myeloma (17 active studies)
- Advanced Solid Tumor (14 active studies)
- Breast Cancer (14 active studies)
- Endometrial Cancer (11 active studies)
- Ovarian Cancer (11 active studies)
- Solid Tumor (10 active studies)
Leading research sponsors in Denver
- University of Colorado, Denver
- AstraZeneca
- Children's Oncology Group
- National Cancer Institute (NCI)
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Denver?
There are approximately 525 recruiting clinical trials in Denver, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Denver pay participants?
Most recruiting trials in Denver compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Denver?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Denver?
The most common conditions under active study in Denver include Multiple Myeloma (17), Advanced Solid Tumor (14), Breast Cancer (14), Endometrial Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Denver?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Denver on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Denver?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Denver?
Recruiting research sites in Denver include Colorado Blood Cancer Institute, National Jewish Health, Sarah Cannon Research Institute at HealthONE, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Denver right now?
The largest active categories in Denver are Cancer & tumors (217), Cardiovascular (17), Mental health & behavior (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.